| abstract |
The present invention has a high efficiency in treating intractable sepsis of test animals caused by Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans, and further, a malignant contact infectious disease The present invention also provides a pharmaceutical composition for preparing an infusion of an antibacterial preparation, which has an effect of clinically significantly increasing the therapeutic potential in treating inflammatory diseases. A composition comprising a finely dispersed powder of colloidal silica having a nanostructure and sodium chloride or dextrose in a specific mass ratio is provided. [Selection figure] None |